MDT vs LIVN stock comparison
Medtronic vs. LivaNova · data as of November 13, 2026
Medtronic (MDT) has a market value of about $131.6B, LivaNova (LIVN) about $5.0B. Over their latest twelve months Medtronic had revenue of $37.5B and LivaNova $1.5B.
On our five checks Medtronic scores higher: 2.2 out of 5 (weak) against 2.0 (weak).
By area, the stronger company is LivaNova on future growth; LivaNova on financial health; Medtronic on shareholder returns.
Medtronic is cheaper on earnings (P/E 25.3 vs. 26.2), while LivaNova grew revenue faster over five years (8.2% vs. 3.8% a year).
Medtronic leads on 13 of the compared lines and LivaNova on 8.
Side by side
| MDT | LIVN | |
|---|---|---|
| Size and price | ||
| Market cap | $131.6B | $5.0B |
| Share price | $102.86 | $91.32 |
| Score | ||
| Overall score (of 5) | 2.2 | 2.0 |
| Value | 0 | 0 |
| Future growth | 2 | 4 |
| Track record | 1 | 1 |
| Financial health | 3 | 4 |
| Shareholder returns | 5 | 1 |
| Valuation | ||
| P/E (TTM) | 25.3 | 26.2 |
| Forward P/E | 17.3 | 20.8 |
| Price / free cash flow | 21.5 | 39.0 |
| Price / sales | 3.5 | 3.3 |
| EV / EBITDA | 15.5 | 23.2 |
| PEG | 3.61 | — |
| DCF value vs. price | −16% | −72% |
| Business | ||
| Revenue | $37.5B | $1.5B |
| Net income | $5.2B | $196M |
| Free cash flow | $6.1B | $129M |
| Net margin | 13.9% | 13.0% |
| Gross margin (5-yr avg.) | 65.9% | 67.7% |
| ROIC (5-yr avg.) | 6.0% | 1.6% |
| Growth | ||
| Revenue growth (1 yr) | 8.4% | 10.7% |
| Revenue growth (5 yrs, per year) | 3.8% | 8.2% |
| EPS growth (5 yrs, per year) | 7.0% | — |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$19.3B | $210M |
| Dividend yield | 2.80% | None |
| Shareholder yield | 3.6% | 0.0% |
| Analysts | ||
| Upside to average target | +2% | +15% |
| Consensus rating | Buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: MDT TTM to July 31, 2026, LIVN TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, Medtronic or LivaNova?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Medtronic scores 2.2 out of 5 and LivaNova 2.0; the table shows where each one is stronger.
Is Medtronic cheaper than LivaNova?
On trailing earnings, Medtronic trades at a P/E of 25.3 and LivaNova at 26.2, so Medtronic is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which grows faster, Medtronic or LivaNova?
Over five years LivaNova grew revenue about 8.2% a year and Medtronic about 3.8% a year.
Which pays a higher dividend?
Medtronic yields 2.80% and LivaNova nothing (no dividend).
Full Medtronic analysis → Full LivaNova analysis →
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.